Variant report

Variant	esv1817453
Chromosome Location	chr6:35755133-35767134
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr6:35765017-35765289	K562	blood:	n/a	n/a
2	BHLHE40	chr6:35758607-35758807	HepG2	liver:	n/a	n/a
3	BHLHE40	chr6:35760699-35760763	K562	blood:	n/a	n/a
4	CEBPB	chr6:35758463-35758813	HepG2	liver:	n/a	n/a
5	CEBPB	chr6:35758462-35758824	IMR90	lung:	n/a	n/a
6	CEBPB	chr6:35762562-35762885	K562	blood:	n/a	n/a
7	CEBPB	chr6:35758461-35758817	K562	blood:	n/a	n/a
8	CEBPB	chr6:35758467-35758814	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr6:35758454-35758819	A549	lung:	n/a	n/a
10	CEBPB	chr6:35758561-35758682	HepG2	liver:	n/a	n/a
11	CEBPB	chr6:35758448-35758812	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr6:35758455-35758789	K562	blood:	n/a	n/a
13	CEBPB	chr6:35756271-35756457	HepG2	liver:	n/a	n/a
14	CEBPB	chr6:35758405-35758921	A549	lung:	n/a	n/a
15	CEBPB	chr6:35758444-35758768	MCF-7	breast:	n/a	n/a
16	CTCF	chr6:35755520-35755670	GM12875	blood:	n/a	n/a
17	CTCF	chr6:35765740-35765890	GM12864	blood:	n/a	n/a
18	CTCF	chr6:35756160-35756310	GM12865	blood:	n/a	n/a
19	CTCF	chr6:35766010-35766063	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr6:35760640-35760790	GM12868	blood:	n/a	n/a
21	CTCF	chr6:35756680-35756830	GM12873	blood:	n/a	chr6:35756799-35756809
22	CTCF	chr6:35760300-35760450	AG04449	skin:	n/a	n/a
23	E2F4	chr6:35759420-35759424	MCF10A-Er-Src	breast:	n/a	n/a
24	E2F6	chr6:35761233-35761368	K562	blood:	n/a	chr6:35761248-35761260
25	E2F6	chr6:35761154-35761630	H1-hESC	embryonic stem cell:	n/a	chr6:35761248-35761260
26	E2F6	chr6:35766297-35766870	H1-hESC	embryonic stem cell:	n/a	n/a
27	E2F6	chr6:35766372-35766946	H1-hESC	embryonic stem cell:	n/a	n/a
28	E2F6	chr6:35761091-35761480	H1-hESC	embryonic stem cell:	n/a	chr6:35761248-35761260
29	EGR1	chr6:35763349-35763621	K562	blood:	n/a	chr6:35763477-35763491 chr6:35763478-35763491 chr6:35763479-35763490 chr6:35763479-35763490 chr6:35763479-35763488
30	EGR1	chr6:35765030-35765252	K562	blood:	n/a	n/a
31	ELF1	chr6:35764865-35765253	GM12878	blood:	n/a	n/a
32	FOXA1	chr6:35764145-35764400	T-47D	breast:	n/a	n/a
33	FOXA1	chr6:35764086-35764407	T-47D	breast:	n/a	n/a
34	GTF2F1	chr6:35765022-35765053	H1-hESC	embryonic stem cell:	n/a	n/a
35	GTF2F1	chr6:35763645-35763723	K562	blood:	n/a	n/a
36	GTF2F1	chr6:35766681-35766722	H1-hESC	embryonic stem cell:	n/a	n/a
37	HNF4A	chr6:35755377-35755745	HepG2	liver:	n/a	chr6:35755619-35755634 chr6:35755620-35755632 chr6:35755620-35755633 chr6:35755620-35755632 chr6:35755619-35755634 chr6:35755620-35755632 chr6:35755619-35755634 chr6:35755618-35755633 chr6:35755619-35755634
38	HNF4A	chr6:35755424-35755827	HepG2	liver:	n/a	chr6:35755619-35755634 chr6:35755620-35755632 chr6:35755620-35755633 chr6:35755620-35755632 chr6:35755619-35755634 chr6:35755620-35755632 chr6:35755619-35755634 chr6:35755618-35755633 chr6:35755619-35755634
39	JUN	chr6:35765331-35765335	H1-hESC	embryonic stem cell:	n/a	n/a
40	MAFF	chr6:35758034-35758157	K562	blood:	n/a	n/a
41	MAFF	chr6:35762574-35762875	K562	blood:	n/a	chr6:35762725-35762739 chr6:35762719-35762737
42	MAFF	chr6:35756435-35756454	HepG2	liver:	n/a	n/a
43	MAFF	chr6:35762658-35762770	HepG2	liver:	n/a	chr6:35762725-35762739 chr6:35762719-35762737
44	MAFK	chr6:35762579-35762870	HepG2	liver:	n/a	chr6:35762726-35762736 chr6:35762726-35762735 chr6:35762722-35762742 chr6:35762721-35762736 chr6:35762725-35762739
45	MAFK	chr6:35762562-35762855	HepG2	liver:	n/a	chr6:35762726-35762736 chr6:35762726-35762735 chr6:35762722-35762742 chr6:35762721-35762736 chr6:35762725-35762739
46	MAFK	chr6:35762633-35762864	Hela-S3	cervix:	n/a	chr6:35762726-35762736 chr6:35762726-35762735 chr6:35762722-35762742 chr6:35762721-35762736 chr6:35762725-35762739
47	MAFK	chr6:35756515-35756538	HepG2	liver:	n/a	n/a
48	MAFK	chr6:35758054-35758231	HepG2	liver:	n/a	n/a
49	MAFK	chr6:35762557-35762899	K562	blood:	n/a	chr6:35762726-35762736 chr6:35762726-35762735 chr6:35762722-35762742 chr6:35762721-35762736 chr6:35762725-35762739
50	MAX	chr6:35766413-35766899	H1-hESC	embryonic stem cell:	n/a	chr6:35766728-35766738

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:35755609-35755659	NB4	blood:	n/a
2	chr6:35765589-35765639	HL-60	blood:	n/a
3	chr6:35765093-35765143	Jurkat	blood:	n/a
4	chr6:35764958-35765008	HAEpiC	amniotic membrane:	n/a
5	chr6:35764958-35765008	ovcar-3	ovarian:	n/a
6	chr6:35766051-35766101	MCF-7	breast:	n/a
7	chr6:35764958-35765008	HRPEpiC	eye:	n/a
8	chr6:35766051-35766101	SAEC	small airway:	n/a
9	chr6:35765146-35765196	NHDF-neo	bronchial:	n/a
10	chr6:35765215-35765265	AG04450	lung:	fetal
11	chr6:35765146-35765196	ECC-1	luminal epithelium:	n/a
12	chr6:35765093-35765143	HRCEpiC	kidney:	n/a
13	chr6:35766021-35766071	HCPEpiC	choroid plexus:	n/a
14	chr6:35765093-35765143	NHDF-neo	bronchial:	n/a
15	chr6:35765146-35765196	HRE	kidney:	n/a
16	chr6:35765093-35765143	HNPCEpiC	eye:	n/a
17	chr6:35766051-35766101	AG09309	skin:	n/a
18	chr6:35764958-35765008	HUVEC	blood vessel:	n/a
19	chr6:35766051-35766101	LNCaP	prostate:	n/a
20	chr6:35765146-35765196	GM19239	blood:	n/a
21	chr6:35762844-35762894	AG04449	skin:	fetal
22	chr6:35765589-35765639	A549	lung:	n/a
23	chr6:35765589-35765639	AG09309	skin:	n/a
24	chr6:35765589-35765639	GM12892	blood:	n/a
25	chr6:35765215-35765265	HMEC	breast:	n/a
26	chr6:35765176-35765226	MCF-7	breast:	n/a
27	chr6:35766021-35766071	HCF	heart:	n/a
28	chr6:35765146-35765196	Jurkat	blood:	n/a
29	chr6:35762844-35762894	HIPEpiC	eye:	n/a
30	chr6:35766051-35766101	AoSMC	blood vessel:	n/a
31	chr6:35766051-35766101	NH-A	brain:	n/a
32	chr6:35762844-35762894	HAEpiC	amniotic membrane:	n/a
33	chr6:35765146-35765196	BE2_C	brain:	n/a
34	chr6:35762844-35762894	GM06990	blood:	n/a
35	chr6:35765589-35765639	MCF10A-Er-Src	breast:	n/a
36	chr6:35765093-35765143	Caco-2	colon:	n/a
37	chr6:35766051-35766101	SK-N-MC	brain:	n/a
38	chr6:35765093-35765143	SK-N-SH	brain:	n/a
39	chr6:35765589-35765639	AG10803	skin:	n/a
40	chr6:35755609-35755659	AG04450	lung:	fetal
41	chr6:35765589-35765639	Jurkat	blood:	n/a
42	chr6:35765215-35765265	LNCaP	prostate:	n/a
43	chr6:35766051-35766101	GM06990	blood:	n/a
44	chr6:35765093-35765143	NH-A	brain:	n/a
45	chr6:35756942-35756992	GM06990	blood:	n/a
46	chr6:35766051-35766101	GM19239	blood:	n/a
47	chr6:35766051-35766101	Caco-2	colon:	n/a
48	chr6:35765589-35765639	HRE	kidney:	n/a
49	chr6:35765176-35765226	NH-A	brain:	n/a
50	chr6:35766051-35766101	NHBE	bronchial:	n/a

No.	Distal block	Cell Line	Cell type
1	chr6:35753847..35759789-chr6:35762486..35768711,9	K562	blood:
2	chr6:35762091..35764853-chr6:35765476..35768100,2	MCF-7	breast:
3	chr6:35744273..35746880-chr6:35754146..35757378,3	K562	blood:
4	chr6:35742984..35745597-chr6:35763979..35765844,2	MCF-7	breast:
5	chr6:35762283..35764266-chr6:35764644..35767426,2	MCF-7	breast:
6	chr6:35753638..35758618-chr6:35762629..35767095,7	K562	blood:
7	chr6:35760015..35761880-chr6:35763280..35765561,2	K562	blood:
8	chr6:35747942..35750162-chr6:35760132..35762411,2	MCF-7	breast:
9	chr6:35762307..35765078-chr6:35772426..35774241,2	MCF-7	breast:
10	chr6:35762091..35764853-chr6:35765476..35768100,2	MCF-7	breast:
11	chr6:35753638..35758618-chr6:35762629..35767095,7	K562	blood:
12	chr6:35760846..35763760-chr6:36163836..36166432,2	K562	blood:
13	chr6:35753847..35759789-chr6:35762486..35768711,9	K562	blood:

Variant related genes	Relation type
CLPS	TF binding region
CLPS	CpG island
ENSG00000137392	chromatin interactions
ENSG00000196748	chromatin interactions
ENSG00000197753	chromatin interactions
ENSG00000246982	chromatin interactions
ENSG00000204140	chromatin interactions
ENSG00000096070	chromatin interactions

Extended variants
information (count: 672 )
Associated
traits (count: 108 )

Variant overlapped rSNPs/rCNVs (count:672 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs540225565	chr6:35755133-35755134	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs555849750	chr6:35755134-35755135	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs574000870	chr6:35755146-35755147	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs113492347	chr6:35755224-35755225	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs544009854	chr6:35755230-35755231	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs562384818	chr6:35755244-35755245	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs376158264	chr6:35755268-35755269	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs532959298	chr6:35755269-35755270	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs372610782	chr6:35755348-35755349	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs544932871	chr6:35755365-35755366	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs560175407	chr6:35755376-35755377	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs111960951	chr6:35755389-35755390	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs548674437	chr6:35755428-35755429	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs567358704	chr6:35755484-35755485	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs531394696	chr6:35755489-35755490	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs549898138	chr6:35755523-35755524	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs6927363	chr6:35755547-35755548	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs540022227	chr6:35755552-35755553	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs558440227	chr6:35755579-35755580	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs369132151	chr6:35755609-35755610	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs373408423	chr6:35755610-35755611	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs567022968	chr6:35755617-35755618	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs57267367	chr6:35755618-35755619	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs534200139	chr6:35755619-35755620	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs371334705	chr6:35755633-35755634	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs373782315	chr6:35755649-35755650	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs12211728	chr6:35755658-35755659	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs371335450	chr6:35755660-35755661	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs200011151	chr6:35755674-35755675	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs201083630	chr6:35755680-35755681	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs141726973	chr6:35755682-35755683	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs561535280	chr6:35755688-35755689	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs373793944	chr6:35755727-35755728	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs201001742	chr6:35755728-35755729	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs367548710	chr6:35755738-35755739	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs372322460	chr6:35755741-35755742	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs529542464	chr6:35755753-35755754	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs376822960	chr6:35755756-35755757	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs201485408	chr6:35755764-35755765	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs372544403	chr6:35755767-35755768	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs377051504	chr6:35755785-35755786	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs544770925	chr6:35755794-35755795	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs560420084	chr6:35755797-35755798	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs369258241	chr6:35755807-35755808	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs550985457	chr6:35755817-35755818	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs569247743	chr6:35755832-35755833	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs537873756	chr6:35755851-35755852	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs542619434	chr6:35755878-35755879	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs560767721	chr6:35755887-35755888	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs531310604	chr6:35755894-35755895	Weak transcription Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:108)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Systemic lupus erythematosus	19279649	CNVD
Retinoblastoma	16790693	CNVD
Acute myocardial infarction	18032375	CNVD
Renal cell carcinoma	19150565	CNVD
Systemic lupus erythematosus	19591781	CNVD
Attention deficit hyperactivity disorder	19287146	CNVD
Autism	19287146	CNVD
Erythema nodosum in leprosy	19287146	CNVD
Henoch-schoenlein purpura	19287146	CNVD
Liver cirrhosis	19287146	CNVD
Systemic lupus erythematosus	19287146	CNVD
Autoimmune disease	19135723	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Systemic lupus erythematosus	19287147	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Lung cancer	19153074	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:89 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:35746400-35755400	Weak transcription	Pancreas	Pancrea
2	chr6:35754200-35755400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr6:35754400-35755200	Enhancers	iPS-15b Cell Line	embryonic stem cell
4	chr6:35754400-35756000	Bivalent Enhancer	Placenta	Placenta
5	chr6:35754600-35755200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr6:35754600-35755200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr6:35754600-35755200	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr6:35754600-35755200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
9	chr6:35754600-35755400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
10	chr6:35754600-35755600	Bivalent Enhancer	Liver	Liver
11	chr6:35754800-35755200	Bivalent Enhancer	Lung	lung
12	chr6:35754800-35755600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr6:35754800-35755600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
14	chr6:35755000-35755200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
15	chr6:35755000-35755200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
16	chr6:35755000-35755200	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
17	chr6:35755000-35755200	Bivalent Enhancer	A549	lung
18	chr6:35755000-35755200	Bivalent Enhancer	HMEC	breast
19	chr6:35755000-35755400	Bivalent Enhancer	HepG2	liver
20	chr6:35755000-35755600	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
21	chr6:35755000-35755600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
22	chr6:35755000-35756000	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
23	chr6:35755200-35755400	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
24	chr6:35755200-35755400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
25	chr6:35755200-35755400	Bivalent Enhancer	Duodenum Mucosa	Duodenum
26	chr6:35755200-35756600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
27	chr6:35755400-35755800	Flanking Active TSS	HepG2	liver
28	chr6:35755400-35757000	Enhancers	Pancreas	Pancrea
29	chr6:35755400-35765600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr6:35755600-35756000	Enhancers	Liver	Liver
31	chr6:35755600-35758600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
32	chr6:35755800-35756400	Enhancers	HepG2	liver
33	chr6:35756400-35756600	Bivalent Enhancer	HepG2	liver
34	chr6:35756600-35756800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
35	chr6:35757000-35760400	Weak transcription	Pancreas	Pancrea
36	chr6:35757800-35759000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
37	chr6:35758400-35758600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr6:35758600-35758800	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
39	chr6:35758800-35760400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
40	chr6:35760400-35760600	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
41	chr6:35760400-35760600	Enhancers	Pancreas	Pancrea
42	chr6:35760400-35761600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
43	chr6:35760600-35760800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
44	chr6:35760600-35760800	Flanking Active TSS	Pancreas	Pancrea
45	chr6:35760600-35760800	Bivalent Enhancer	Stomach Smooth Muscle	stomach
46	chr6:35760600-35762600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
47	chr6:35760800-35761200	Enhancers	Pancreas	Pancrea
48	chr6:35761200-35761400	Active TSS	Pancreas	Pancrea
49	chr6:35761200-35761600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
50	chr6:35761400-35761600	Flanking Active TSS	Pancreas	Pancrea

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links